These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16021026)

  • 1. Implications of LDL subclass B in patients at cardiovascular risk.
    Moredich C; Kark D; Keresztes P
    Nurse Pract; 2005 Jul; 30(7):16-8, 23, 26, passim; quiz 29-31. PubMed ID: 16021026
    [No Abstract]   [Full Text] [Related]  

  • 2. The primary target. Taking aim at LDL levels to prevent cardiovascular disease.
    Mason CM
    Adv Nurse Pract; 2007 Dec; 15(12):55-8. PubMed ID: 20014676
    [No Abstract]   [Full Text] [Related]  

  • 3. Do patients on statins also need niacin?
    Jones KW
    JAAPA; 2013 Jul; 26(7):9-10. PubMed ID: 23923280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The facts behind niacin.
    Hochholzer W; Berg DD; Giugliano RP
    Ther Adv Cardiovasc Dis; 2011 Oct; 5(5):227-40. PubMed ID: 21893559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 6. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
    Rankin FM; Cohen JD
    J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
    [No Abstract]   [Full Text] [Related]  

  • 7. The nurse practitioner's role in helping patients achieve lipid goals with statin therapy.
    Mason CM
    J Am Acad Nurse Pract; 2005 Jul; 17(7):256-62. PubMed ID: 15982245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total lipid management and residual risk: beyond statin therapy.
    Evans M
    Br J Hosp Med (Lond); 2011 Mar; 72(3):132-6. PubMed ID: 21475092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program.
    Blonde L; Dempster J; Gallivan JM; Warren-Boulton E
    J Am Acad Nurse Pract; 2006 Nov; 18(11):524-33. PubMed ID: 17064330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?
    Kostapanos MS; Katsiki N; Elisaf MS; Mikhailidis DP
    Curr Vasc Pharmacol; 2012 Mar; 10(2):173-7. PubMed ID: 22250844
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular primary prevention: how high should we set the bar?
    Prasad V; Vandross A
    Arch Intern Med; 2012 Apr; 172(8):656-9; discussion 659. PubMed ID: 22529231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit.
    Mitka M
    JAMA; 2010 Jan; 303(3):211-2. PubMed ID: 20085945
    [No Abstract]   [Full Text] [Related]  

  • 13. Atherogenic dyslipidemia.
    Hayden MR
    J Cardiometab Syndr; 2006; 1(3):166-7. PubMed ID: 17679821
    [No Abstract]   [Full Text] [Related]  

  • 14. The heart of the matter: reducing CVD risk.
    Hayman LL; Kamau MW; Stuart-Shor EM
    Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertriglyceridemia and cardiovascular disease management.
    Codario RA
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
    [No Abstract]   [Full Text] [Related]  

  • 16. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
    Olsson AG
    Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in prevention: improving cardiovascular risk management among human immunodeficiency virus-positive individuals.
    Farley JE; Tudor C; Dennison CR
    J Cardiovasc Nurs; 2010; 25(4):259-60. PubMed ID: 20539159
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality.
    Pirillo A; Norata GD; Catapano AL
    Curr Pharm Des; 2013; 19(21):3841-57. PubMed ID: 23286430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options for lowering LDL-C in type 2 diabetes: a nurse practitioner's perspective.
    Lew KN; Kent DJ; Muñoz AA; Melkus GD
    J Am Assoc Nurse Pract; 2013 Sep; 25(9):488-94. PubMed ID: 24170653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Diabetes Association indications for statins in diabetes: is there evidence?
    Eldor R; Raz I
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S384-91. PubMed ID: 19875586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.